Skip to content
Peptideworth

Ranked board

Sermorelin sellers, and what the human trials actually show

Sermorelin is the single most widely sold peptide on this site and, judged against the published human record for the uses it is sold for, the most consistently oversold. It is not a close call and the counts below are unusually uniform. A board can be worth publishing precisely because every row says the same uncomfortable thing.

By Grant Delaney, Research Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

What gets on this board

Every published review whose dispensed list includes a product we have graded as sermorelin. A product that sells sermorelin only in combination with a compound inside the FDA compounding restriction is excluded and named in the register below, because ranking it would mean ranking a seller of the restricted half.

What decides the order

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

What the grading found

0/13

Claims that match the trials

Across every one of these companies' sermorelin products that we have graded.

4/13

Name their pharmacy

A telehealth brand is almost never the pharmacy that fills the order.

0

Publish a readable certificate

Of every company reviewed on this site, not just those on this board.

The ranking

Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.

Only sermorelin products are counted here. Where a company sells sermorelin alongside a restricted compound in one product, that product is reported on its review and counted on no board at all.

CompanyClaims vs. trialsDisclosesVisit
Invigor Medical

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Pharmacy namedTesting shown
Visit
PeptidesRx

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Pharmacy namedTesting shown
Not linked
The Edit Health

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Pharmacy namedTesting shown
Visit
Auren Rx

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Pharmacy named
Visit
AgelessRx

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Testing shown
Visit
Eden

Checked August 2026

FDA letter — marketing

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Testing shown
Visit
Maximus

Checked August 2026

FDA letter — marketing

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Testing shown
Visit
Valhalla Vitality

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Testing shown
Visit
Defy Medical

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit
Hone Health

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit
Joi + Blokes

Checked August 2026

FDA letter — marketing

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit
Lighter You

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit
Vyvron

Checked August 2026

0/10%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit

How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.

What this board does not measure

Whether it works

A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.

Clinical care

We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.

Price

Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.

Product quality

Not one company reviewed here publishes a certificate of analysis a customer can read. Until that changes, nothing on this site can tell you what is in a vial.

Considered, and not on this board

3 companies were inside this board's candidate net and did not meet its rule. Each one has a published review here, and none was left off for an unflattering result.

  • 1st Optimal

    Sells sermorelin, but only as part of “Sermorelin and CJC-1295” — and the other half of that combination is inside the FDA compounding restriction this site will not rank sellers against. The product is reported on its review; it is not counted here.

  • Regenics

    Dispenses Tesamorelin — but nothing whose molecule is sermorelin, so it has no sermorelin claim of its own for us to grade.

  • Trellis Vitality

    Dispenses Tesamorelin — but nothing whose molecule is sermorelin, so it has no sermorelin claim of its own for us to grade.

Frequently asked questions

Why does almost every sermorelin row score zero?

Because sermorelin's human trial record is largely a diagnostic and paediatric one, and the things it is sold for on these sites — deeper sleep, faster recovery, body composition in healthy adults — are not what those trials measured. A zero here means we found no trial addressing the claim as the company makes it. It does not mean the molecule does nothing, and it does not mean the company is dishonest.

Is sermorelin affected by the FDA compounding restriction?

Sermorelin itself is not on the restricted list that has emptied this network's BPC-157, TB-500, CJC-1295 and ipamorelin boards. Combination products are the complication: a preparation sold as sermorelin plus CJC-1295 contains a restricted compound, so we do not rank its seller here. The register below names the company that applies to.

Nothing pinned

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.